Faculty

Institution

Unit

Venue

Branimir Sikic

Professor of Medicine Oncology Emeritus

Stanford University

Affiliations

School of Medicine

Medicine

Oncology

Branimir Sikic is currently serving as a Medicine Professor of Medicine Oncology Emeritus at Stanford University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Branimir Sikic

Stanford University

Professor of Medicine Oncology Emeritus

You can click a keyword to filter the displayed items

oncology pharmacology cancer research medicine cancer treatment cancer care medicinal research cancer biology radiation oncology pharmacotherapy clinical research tumor biology cancer genomics cancer genetics immunology drug resistance cancer immunotherapy anti-cancer agents molecular cancer ovarian cancer cancer management clinical trials gynecologic oncology leukemia pharmacokinetics multidrug resistance enzyme inhibition cellular therapy tumor targeting clinical pharmacology thoracic oncology cancer cells oncogenes brain tumor research advanced solid tumors hematological malignancies respiratory medicine drug trials medical genetics clinical radiation oncology acute myeloid leukemia experimental medicine cytogenetics radiation therapy drug targeting therapeutic efficacy advanced solid malignancies molecular cell biology clinical investigation antibody engineering cell regulation clinical therapeutics tumor suppressors immune checkpoint inhibitors therapy resistance treatment development cancer prevention treatment effects biomedical research colorectal cancer breast oncology small cell carcinoma genome analysis clinical immunology combination chemotherapy dna cross-linking phase ii study clinical medicine ovarian carcinoma clinical studies pharmacokinetic study human sarcoma mutants mutant p-glycoprotein growth inhibition pulmonary toxicity liposomal doxorubicin

Notable Scholarly Works

Notable Federal Grants

Collaborators

Continuous 72-H Infusion of Zosuquidar With Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Stratified for Leukemic Blast P-Glycoprotein Phenotype. Cancer Chemotherapy and Pharmacology (2024)

John F. MarcellettiBranimir I. Sikic

personalized medicinemedicinepharmacologytherapeutic targetsacute myeloid leukemiacellular therapyoncologycancer researchmedical mycologycancer carecancer treatmenttherapeutic efficacyanti-cancer agentsradiation oncologytumor targetingmedicinal researchhematologyclinical radiation oncologypharmacotherapy

A Clinical Trial of Zosuquidar Plus Gemtuzumab Ozogamicin (Go) in Relapsed or Refractory Acute Myeloid Leukemia (Rr Aml): Evidence of Efficacy Based on Leukemic Blast P-Glycoprotein Functional Phenotype. Cancer Chemotherapy and Pharmacology (2023)

John F. MarcellettiBranimir I. Sikic

hematologygemtuzumab ozogamicinmedicineoncologycancer researchclinical trials

A Phase I Trial of the Abcb1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology (2023)

Paula M. FracassoGeorge A. FisherSherry A. GoodnerJan H. BeumerMerrill J. EgorinCarole L. FearsJonathan D. WildiGary J. JonesTillman E. PearceBranimir I. Sikic

medicinepharmacologytherapeutic targetsoncologycancer researchcancer carecancer treatmentadvanced solid tumorsclinical trialsanti-cancer agentsradiation oncologymedicinal researchdrug trialsoral valspodarcancer managementenzyme inhibitionclinical researchpharmacotherapytreatment development

Carboplatin-Induced Upregulation of Pan β-Tubulin and Class III β-Tubulin is Implicated in Acquired Resistance and Cross-Resistance of Ovarian Cancer. Cellular and Molecular Life Sciences (2023)

Margareta Pernar KovačVanja TadićJuran KraljGeorge E. DuranAlessia StefanelliDarija Stupin PolančecSanja DabelićNiko BačićMaja T. TomicicPetra HeffeterBranimir I. SikicAnamaria Brozovic

induced resistancecancer biologycell biologypharmacologymolecular physiologymolecular and cellular biologyoncologycancer researchcell regulationcarboplatin-induced upregulationmolecular biologymembrane biologypan b-tubulinovarian cancerclass iii b-tubulingynecologic oncologymolecular sciencecellular biologycancer geneticscellular physiologycellular biochemistry

Data From Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. (2023)

Kevin G. ChenYan C. WangMarci E. SchanerBrian FranciscoGeorge E. DuránDejan JuricLyn M. HuffHesed Padilla-NashThomas RiedTito FojoBranimir I. Sikic

epigeneticsgeneticstumor biologymolecular geneticstherapy resistancemolecular cancercancer biologydermatologyepigenetic modelingmultidrug-resistant cellsgenomicspharmacologyepigenomicsgenome biologyhuman geneticscancer geneticsmedicinal researchtreatment development

Data From High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors. (2023)

Markus BredelClaudia BredelDejan JuricGriffith R. HarshHannes VogelLawrence D. RechtBranimir I. Sikic

bioinformaticscomputational genomicsneuroscienceneurogeneticsbiomedical informaticsneuroradiologygenetic alterationshigh-resolution genome-wide mappingdata sciencebrain tumor researchneurologycancer genomicsneuro-oncologymedical geneticsgenomicsgenome biologyneuroimagingepigenomicscancer genetics

Data From Mechanisms of Resistance to Cabazitaxel. (2023)

George E. DuranYan C. WangE. Brian FranciscoJohn C. RoseFrancisco J. MartinezJohn CollerDiana BrassardPatricia VrignaudBranimir I. Sikic

biophysicsdrug resistancepharmacologydrug discoverystructural biology

Supplemental Tables 1-4 From a Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-Dll4) in Patients With Previously Treated Solid Tumors. (2023)

David C. SmithPeter D. EisenbergGeorgy ManikhasRashmi ChughMatthew A. GubensRobert J. StaggAnn M. KapounLu XuJakob DupontBranimir Sikic

cellular therapymedicinecancer researchradiation oncologyoncologycancer managementexpansion studycancer carepharmacologycancer treatmentmedicinal researchsolid tumors

Supplementary Figure 2 From Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel Myc-Interacting Genes in Human Gliomas. (2023)

Markus BredelClaudia BredelDejan JuricGriffith R. HarshHannes VogelLawrence D. RechtBranimir I. Sikic

cancer genomicstumor biologysystems neurosciencehuman gliomasradiation oncologygliomagenesis pathway mapscancer biologyneuro-oncologyneurosciencebrain tumor researchgliomasneurologycancer genetics

Supplementary Information From Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. (2023)

Kevin G. ChenYan C. WangMarci E. SchanerBrian FranciscoGeorge E. DuránDejan JuricLyn M. HuffHesed Padilla-NashThomas RiedTito FojoBranimir I. Sikic

cancer genomicstumor biologygeneticsepigeneticsmolecular geneticssupplementary informationmolecular cancercancer biologydermatologyepigenetic modelingmultidrug-resistant cellsgenomicsimmunologygenome biologygene expressioncancer geneticsmedicinal research

1
2
3
4
5
28
10 / page

Branimir Sikic

Professor of Medicine Oncology Emeritus

Stanford University

Affiliations

School of Medicine

Medicine

Oncology

Branimir Sikic is currently serving as a Medicine Professor of Medicine Oncology Emeritus at Stanford University.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Branimir Sikic

Stanford University

Professor of Medicine Oncology Emeritus

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

John F. MarcellettiBranimir I. Sikic

hematologygemtuzumab ozogamicinmedicineoncologycancer researchclinical trials

A Phase I Trial of the Abcb1 Inhibitor, Oral Valspodar, in Combination With Paclitaxel in Patients With Advanced Solid Tumors. American Journal of Clinical Oncology (2023)

Paula M. FracassoGeorge A. FisherSherry A. GoodnerJan H. BeumerMerrill J. EgorinCarole L. FearsJonathan D. WildiGary J. JonesTillman E. PearceBranimir I. Sikic

Carboplatin-Induced Upregulation of Pan β-Tubulin and Class III β-Tubulin is Implicated in Acquired Resistance and Cross-Resistance of Ovarian Cancer. Cellular and Molecular Life Sciences (2023)

Margareta Pernar KovačVanja TadićJuran KraljGeorge E. DuranAlessia StefanelliDarija Stupin PolančecSanja DabelićNiko BačićMaja T. TomicicPetra HeffeterBranimir I. SikicAnamaria Brozovic

Data From Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. (2023)

Kevin G. ChenYan C. WangMarci E. SchanerBrian FranciscoGeorge E. DuránDejan JuricLyn M. HuffHesed Padilla-NashThomas RiedTito FojoBranimir I. Sikic

Data From High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors. (2023)

Markus BredelClaudia BredelDejan JuricGriffith R. HarshHannes VogelLawrence D. RechtBranimir I. Sikic

Data From Mechanisms of Resistance to Cabazitaxel. (2023)

George E. DuranYan C. WangE. Brian FranciscoJohn C. RoseFrancisco J. MartinezJohn CollerDiana BrassardPatricia VrignaudBranimir I. Sikic

biophysicsdrug resistancepharmacologydrug discoverystructural biology

Supplemental Tables 1-4 From a Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-Dll4) in Patients With Previously Treated Solid Tumors. (2023)

David C. SmithPeter D. EisenbergGeorgy ManikhasRashmi ChughMatthew A. GubensRobert J. StaggAnn M. KapounLu XuJakob DupontBranimir Sikic

cellular therapymedicinecancer researchradiation oncologyoncologycancer managementexpansion studycancer carepharmacologycancer treatmentmedicinal researchsolid tumors

Supplementary Figure 2 From Functional Network Analysis Reveals Extended Gliomagenesis Pathway Maps and Three Novel Myc-Interacting Genes in Human Gliomas. (2023)

Markus BredelClaudia BredelDejan JuricGriffith R. HarshHannes VogelLawrence D. RechtBranimir I. Sikic

cancer genomicstumor biologysystems neurosciencehuman gliomasradiation oncologygliomagenesis pathway mapscancer biologyneuro-oncologyneurosciencebrain tumor researchgliomasneurologycancer genetics

Supplementary Information From Genetic and Epigenetic Modeling of the Origins of Multidrug-Resistant Cells in a Human Sarcoma Cell Line. (2023)

Kevin G. ChenYan C. WangMarci E. SchanerBrian FranciscoGeorge E. DuránDejan JuricLyn M. HuffHesed Padilla-NashThomas RiedTito FojoBranimir I. Sikic

1
2
3
4
5
28
10 / page

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Stanton L. Gerson

Institution

Case Western Reserve University

stem cell

haematopoiesis

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Michael Grever

Institution

Ohio State University

hematologic malignancies

pathology

Frank L. Meyskens

Institution

University of California, Irvine

oncology

cancer research

Patricia LoRusso

Institution

Yale University

drug trial

cancer treatment

David P Carbone

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Mark J. Ratain

Institution

University of Chicago

preclinical drug evaluation

pharmacoeconomics

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine

Similar Faculty Members

Afshin Dowlati

Institution

Case Western Reserve University

cancer letter

bronchial neoplasm

Stanton L. Gerson

Institution

Case Western Reserve University

stem cell

haematopoiesis

Peter J. O'Dwyer

Institution

University of Pennsylvania

oncology

pharmacology

Heather Wakelee

Institution

Stanford University

radiation oncology

mesothelioma

Michael Grever

Institution

Ohio State University

hematologic malignancies

pathology

Frank L. Meyskens

Institution

University of California, Irvine

oncology

cancer research

Patricia LoRusso

Institution

Yale University

drug trial

cancer treatment

David P Carbone

Institution

Ohio State University

applied artificial intelligence

multidisciplinary ai

Mark J. Ratain

Institution

University of Chicago

preclinical drug evaluation

pharmacoeconomics

Seongho Kim

Institution

Wayne State University

data analysis

personalized medicine